Redefining Treasury for Consumer and Healthcare Sectors

This technical report discusses the evolving role of treasury functions within healthcare, consumer, and wellness (HCW) companies amidst significant industry changes. It outlines the necessity for treasury to transform from a traditional operational role into a strategic capability that supports agile and resilient business operations. The report details the pressures facing pharmaceutical companies due to patent expirations and the urgent need for innovation in drug development, emphasizing the importance of artificial intelligence in accelerating research and reducing costs. It further examines how changing consumer behaviors, influenced by new weight-loss drugs, are necessitating adaptations in product strategies for consumer goods firms. Additionally, it explains the transformation in liquidity management and the necessity for dynamic treasury operations that align with faster business cycles. The paper concludes by discussing opportunities for treasury to leverage digital assets and innovative financing solutions to enhance operational efficiency and support growth in an evolving market landscape.